Abstract:Diet and the gut microbiota have a profound influence on physiology and health, however, mechanisms are still emerging. Here we outline several pathways that gut microbiota products, particularly short-chain fatty acids (SCFAs), use to maintain gut and immune homeostasis. Dietary fibre is fermented by the gut microbiota in the colon, and large quantities of SCFAs such as acetate, propionate, and butyrate are produced. Dietary fibre and SCFAs enhance epithelial integrity and thereby limit systemic endotoxemia. Moreover, SCFAs inhibit histone deacetylases (HDAC), and thereby affect gene transcription. SCFAs also bind to 'metabolite-sensing' G-protein coupled receptors (GPCRs) such as GPR43, which promotes immune homeostasis. The enormous amounts of SCFAs produced in the colon are sufficient to lower pH, which affects the function of proton sensors such as GPR65 expressed on the gut epithelium and immune cells. GPR65 is an anti-inflammatory Gαs-coupled receptor, which leads to the inhibition of inflammatory cytokines. The importance of GPR65 in inflammatory diseases is underscored by genetics associated with the missense variant I231L (rs3742704), which is associated with human inflammatory bowel disease, atopic dermatitis, and asthma. There is enormous scope to manipulate these pathways using specialized diets that release very high amounts of specific SCFAs in the gut, and we believe that therapies that rely on chemically modified foods is a promising approach. Such an approach includes high SCFA-producing diets, which we have shown to decrease numerous inflammatory western diseases in mouse models. These diets operate at many levels - increased gut integrity, changes to the gut microbiome, and promotion of immune homeostasis, which represents a new and highly promising way to prevent or treat human disease.

Short-chain fatty acids: linking diet, the microbiome and immunity

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

Regulation of immune cell function by short-chain fatty acids

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

The role of short-chain fatty acids in immunity, inflammation and metabolism

Regulation of short-chain fatty acids in the immune system

Research progress on the roles of short chain fatty acids in intestinal mucosa homeostasis immune regulation

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease

The emerging role of microbiota-derived short-chain fatty acids in immunometabolism

SCFA: mechanisms and functional importance in the gut

Short‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells

Dietary fiber and SCFAs in the regulation of mucosal immunity

A major mechanism for immunomodulation: Dietary fibres and acid metabolites

Regulation of inflammation by short chain fatty acids

The role of short-chain fatty acids in health and disease

Short-chain fatty acids in diseases

Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy

Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability

Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?